Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000278526, formally known as "ST7 overlapping transcript 3 conserved region 2" (ST7-OT3_2), is classified as a miscellaneous non-coding RNA rather than a protein-coding gene or a therapeutically actionable molecular target[1]. It is annotated in Ensembl and other genomic databases as being overlapping with the ST7 locus, but there is no evidence for a role in disease, protein function, druggability, or clinical utility as a receptor, enzyme, or related therapeutic target[1][5][7].\n\nThe nomenclature and very limited data indicate this entry is not a canonical therapeutic target, nor does it correspond to a protein or classical functional gene product. There are no known drugs, clinical indications, or characterized molecular functions associated with this entity. This entry is best classified as "not a target" and flagged as containing insufficient or incorrect information for typical therapeutic target annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST7 overlapping transcript 3 conserved region 2 (ST7-OT3_2).